Dysphagia Management Market Size to Exceed USD 7.56 Bn by 2032

The Dysphagia Management Market, estimated at USD 4.96 Bn in 2025, is expected to exhibit a CAGR of 6.2% and reach USD 7.56 Bn by 2032.

The market growth is driven by increasing demand for innovative and effective drugs across diverse therapeutic areas. Advances in drug discovery, biopharmaceuticals, and digital technologies are improving treatment outcomes and operational efficiency. Supportive regulations, rising R&D investments, and a strong focus on patient-centric care are creating new opportunities for pharmaceutical companies.

An increase in research and development activities by the key players in the market is expected to drive the growth of the market over the forecast period. For instance, on August 11, 2021, an article published by National Centre for Biotechnology Information (NCBI) states emerging role of ultrasound in Dysphagia assessment and interventions include ultrasound imaging of the muscles involved in swallowing, tongue movement, and hyolaryngeal excursion, as well as ultrasound-guided treatments for dysphagia. It is necessary to provide diagnostic and prognostic value, ultrasonography, a portable, simple-to-use, and inexpensive technique, could complement videofluoroscopic swallowing study as a first-line screening and follow-up tool for the evaluation of swallowing function in addition to being non-invasive.

Global Dysphagia Management Market – Impact of Coronavirus (COVID-19) Pandemic

The COVID-19 pandemic and lockdowns in various countries across the globe have impacted the financial status of businesses across all sectors, including the private healthcare sector. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry, mainly due to strict lockdowns in several regions. Private healthcare is one such sector that has been impacted significantly by the COVID-19 pandemic.

There were three main ways that COVID-19 influenced the economy: directly by impacting supply and demand, indirectly by disrupting distribution networks, and economically by having an effect on businesses and financial markets. For instance,an article published by National Center for Biotechnology Information (NCBI) on November 10, 2020 states dysphagia is common in patients admitted to the intensive care unit or ward for respiratory problems related to COVID-19. An article describes the critical role of intensive swallowing rehabilitation in the management of dysphagia associated with this condition, including therapeutic airway weaning in individuals with a tracheostomy.

The COVID pandemic has changed the homeostasis of the medical world and is affecting millions of people worldwide. The global crisis has consequences for the world economy in addition to health.

Global Dysphagia Management Market: Key Developments

On October 25, 2022, AstraZeneca, a Sweden based pharmaceutical company announced update on MESSINA phase III trail for Fasenra in Eosinophilic esophagitis. Advanced results from the MESSINA Phase III trial showed that AstraZeneca's Fasenra (benralizumab) failed to meet one of  two key endpoints. Fasenra showed a statistically significant improvement in histologic disease, but no change in dysphagia symptoms compared to placebo in EoE patients  aged 12 years or older.

On May 1, 2021, Bracco Diagnostics, an Italy-based healthcare company introduced the modified barium swallow study (MBSS), also known as the videofluoroscopic swallow study (VFSS), uses barium sulfate radiographic contrast agents of various viscosities to assess swallowing physiology and diagnose dysphagia. Studies show that standardization of the procedure and its materials optimizes the ability to detect dysphagia and minimizes radiation, resulting in safer videofluoroscopy examinations.

Browse 25 Market Data Tables and 27 Figures spread through 170 Pages and in-depth TOC on “Global Dysphagia Management Market”- Forecast to 2030 By Product (Drugs, Feeding tubes, Nutritional solutions), By Indication (Oropharangeal Dysphagia, Esophageal Dysphagia), By Distribution channels (Hospital pharmacies, retail pharmacies, drug stores, speciality clinics),  and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

To know the latest trends and insights prevalent in this market, click the link below:

https://www.coherentmarketinsights.com/market-insight/dysphagia-management-market-3612

Key Takeaways of the Global Dysphagia Management Market:

• The Global Dysphagia Management Market is expected to exhibit a CAGR of 6.2% during the forecast period owing to an increase in the adoption of various strategies such as product launch by the key players in the market. For instance, on October 15, 2020 thick-It brand by Kent Precision Foods Group, Inc, U.S.-based company, which provide nutritive supplements, launched Clear Advantage HydraICE Electrolyte Freezer Pop, which states that Although the pineapple-flavored frozen pop is thickened to level 2, which is a bit thick for people with swallowing difficulties, 11 of the 11 health professionals surveyed agreed to offer the frozen pop to residents with or without swallowing difficulties.
• It explores potential revenue opportunities in various segments and explains attractive investment proposition matrices for these markets.
• This study also provides key insights into market drivers, restraints, opportunities, new drug launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• Major players operating in the global dysphagia management market include Eisai Co. Ltd, C.R. Bard Inc. (Becton, Dickinson and Company), Hormel Health Labs, AstraZeneca, Cipla Ltd, Nestle Health Science, Kent Precision Food Group Inc., Bracco Diagnostics Inc., Phagenesis Ltd, Nutricia Advanced Medical Nutrition, Cook medical Inc.
• The global dysphagia management market report serves various stakeholders in the industry, including investors, suppliers, pharmaceutical manufacturers, distributors, new entrants, and financial analysts.
• Various strategy matrices used in analyzing global dysphagia management market would facilitate stakeholders' decision-making.